JIANG Bin, LUO Cheng-wei. PhaseⅠ Study of Sorafenib in Patients with Refractory or Relapsed Acute Leukemias∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 273-274. DOI: 10.3969/j.issn.1671-5144.2011.05.014
|
Citation:
|
JIANG Bin, LUO Cheng-wei. PhaseⅠ Study of Sorafenib in Patients with Refractory or Relapsed Acute Leukemias∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 273-274. DOI: 10.3969/j.issn.1671-5144.2011.05.014
|
JIANG Bin, LUO Cheng-wei. PhaseⅠ Study of Sorafenib in Patients with Refractory or Relapsed Acute Leukemias∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 273-274. DOI: 10.3969/j.issn.1671-5144.2011.05.014
|
Citation:
|
JIANG Bin, LUO Cheng-wei. PhaseⅠ Study of Sorafenib in Patients with Refractory or Relapsed Acute Leukemias∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 273-274. DOI: 10.3969/j.issn.1671-5144.2011.05.014
|
DownLoad: